Quantitative Analysis of Surface Plasma Membrane Proteins of Primary and Metastatic Melanoma Cells

Overview

Journal J Proteome Res

Publisher American Chemical Society

Specialty Biochemistry

Date 2008 Apr 16

PMID 18410138

Citations 12

Authors

Haibo Qiu

Yinsheng Wang

Affiliations

Soon will be listed here.

Abstract

Plasma membrane proteins play critical roles in cell-to-cell recognition, signal transduction and material transport. Because of their accessibility, membrane proteins constitute the major targets for protein-based drugs. Here, we described an approach, which included stable isotope labeling by amino acids in cell culture (SILAC), cell surface biotinylation, affinity peptide purification and LC-MS/MS for the identification and quantification of cell surface membrane proteins. We applied the strategy for the quantitative analysis of membrane proteins expressed by a pair of human melanoma cell lines, WM-115 and WM-266-4, which were derived initially from the primary and metastatic tumor sites of the same individual. We were able to identify more than 100 membrane and membrane-associated proteins from these two cell lines, including cell surface histones. We further confirmed the surface localization of histone H2B and three other proteins by immunocytochemical analysis with confocal microscopy. The contamination from cytoplasmic and other nonmembrane-related sources is greatly reduced by using cell surface biotinylation and affinity purification of biotinylated peptides. We also quantified the relative expression of 62 identified proteins in the two types of melanoma cells. The application to quantitative analysis of membrane proteins of primary and metastatic melanoma cells revealed great potential of the method in the comprehensive identification of tumor progression markers as well as in the discovery of new protein-based therapeutic targets.

Citing Articles

iTRAQ-based proteomic study on monocyte cell model discovered an association of LAMP2 downregulation with HIV-1 latency.

Yin L, Wang Q, Liu S, Chen J, Zhang Y, Lu L Proteome Sci. 2024; 22(1):6.

PMID: 38750478 PMC: 11095035. DOI: 10.1186/s12953-024-00230-3.

Systematic characterization of extracellular glycoproteins using mass spectrometry.

Sun F, Suttapitugsakul S, Wu R Mass Spectrom Rev. 2021; 42(2):519-545.

PMID: 34047389 PMC: 8627532. DOI: 10.1002/mas.21708.

Externalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer Cells.

Albaret M, Vermot-Desroches C, Pare A, Roca-Martinez J, Malet L, Esseily J Cancers (Basel). 2018; 10(11).

PMID: 30453567 PMC: 6266717. DOI: 10.3390/cancers10110452.

State of the art in tumor antigen and biomarker discovery.

Even-Desrumeaux K, Baty D, Chames P Cancers (Basel). 2013; 3(2):2554-96.

PMID: 24212823 PMC: 3757432. DOI: 10.3390/cancers3022554.

A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness.

Grau L, Luque-Garcia J, Gonzalez-Peramato P, Theodorescu D, Palou J, Fernandez-Gomez J PLoS One. 2013; 8(1):e53328.

PMID: 23308193 PMC: 3540081. DOI: 10.1371/journal.pone.0053328.

References

Jang J, Hanash S . Profiling of the cell surface proteome. Proteomics. 2003; 3(10):1947-54. DOI: 10.1002/pmic.200300563. View

Ojcius D, Muller S, Young J, Jiang S . Plasma membrane-associated proteins with the ability to partially inhibit perforin-mediated lysis. Immunol Lett. 1991; 28(2):101-8. DOI: 10.1016/0165-2478(91)90106-k. View

Pasquali C, Fialka I, Huber L . Subcellular fractionation, electromigration analysis and mapping of organelles. J Chromatogr B Biomed Sci Appl. 1999; 722(1-2):89-102. DOI: 10.1016/s0378-4347(98)00314-4. View

Santoni V, Molloy M, Rabilloud T . Membrane proteins and proteomics: un amour impossible?. Electrophoresis. 2000; 21(6):1054-70. DOI: 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.0.CO;2-8. View

Qiu H, Wang Y . Probing adenosine nucleotide-binding proteins with an affinity-labeled nucleotide probe and mass spectrometry. Anal Chem. 2007; 79(15):5547-56. PMC: 2637870. DOI: 10.1021/ac0622375. View

Si Z, Hersey P . Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer. 1993; 54(1):37-43. DOI: 10.1002/ijc.2910540107. View

Loyet K, Ouyang W, Eaton D, Stults J . Proteomic profiling of surface proteins on Th1 and Th2 cells. J Proteome Res. 2005; 4(2):400-9. DOI: 10.1021/pr049810q. View

Chen W, Yu L, Strittmatter E, Thrall B, Camp 2nd D, Smith R . Detection of in situ labeled cell surface proteins by mass spectrometry: application to the membrane subproteome of human mammary epithelial cells. Proteomics. 2003; 3(8):1647-51. DOI: 10.1002/pmic.200300468. View

Xiang R, Shi Y, Dillon D, Negin B, Horvath C, Wilkins J . 2D LC/MS analysis of membrane proteins from breast cancer cell lines MCF7 and BT474. J Proteome Res. 2004; 3(6):1278-83. DOI: 10.1021/pr049852e. View

10.

Lunter P, van Kilsdonk J, van Beek H, Cornelissen I, Bergers M, Willems P . Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Cancer Res. 2005; 65(19):8801-8. DOI: 10.1158/0008-5472.CAN-05-0378. View

11.

van Kempen L, van den Oord J, van Muijen G, Weidle U, Bloemers H, Swart G . Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol. 2000; 156(3):769-74. PMC: 1876839. DOI: 10.1016/S0002-9440(10)64943-7. View

12.

Johnson J . Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev. 2000; 18(3):345-57. DOI: 10.1023/a:1006304806799. View

13.

Scheurer S, Rybak J, Roesli C, Brunisholz R, Potthast F, Schlapbach R . Identification and relative quantification of membrane proteins by surface biotinylation and two-dimensional peptide mapping. Proteomics. 2005; 5(11):2718-28. DOI: 10.1002/pmic.200401163. View

14.

Ramus C, Gonzalez de Peredo A, Dahout C, Gallagher M, Garin J . An optimized strategy for ICAT quantification of membrane proteins. Mol Cell Proteomics. 2005; 5(1):68-78. DOI: 10.1074/mcp.M500205-MCP200. View

15.

Speers A, Wu C . Proteomics of integral membrane proteins--theory and application. Chem Rev. 2007; 107(8):3687-714. DOI: 10.1021/cr068286z. View

16.

Cavallaro U, Christofori G . Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004; 4(2):118-32. DOI: 10.1038/nrc1276. View

17.

Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson J . Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 1997; 57(11):2295-303. View

18.

Sostaric E, Georgiou A, Wong C, Watson P, Holt W, Fazeli A . Global profiling of surface plasma membrane proteome of oviductal epithelial cells. J Proteome Res. 2006; 5(11):3029-37. DOI: 10.1021/pr060366w. View

19.

Klein W, Wu B, Zhao S, Wu H, Klein-Szanto A, Tahan S . Increased expression of stem cell markers in malignant melanoma. Mod Pathol. 2006; 20(1):102-7. DOI: 10.1038/modpathol.3800720. View

20.

Luca M, Hunt B, Bucana C, Johnson J, Fidler I, Bar-Eli M . Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res. 1993; 3(1):35-41. DOI: 10.1097/00008390-199304000-00006. View